These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2379384

  • 1. Imipenem pharmacokinetics in patients with burns.
    Boucher BA, Hickerson WL, Kuhl DA, Bombassaro AM, Jaresko GS.
    Clin Pharmacol Ther; 1990 Aug; 48(2):130-7. PubMed ID: 2379384
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA, Hudson JQ, Hill DM, Swanson JM, Wood GC, Laizure SC, Arnold-Ross A, Hu ZY, Hickerson WL.
    Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics of imipenem in burn patients.
    Dailly E, Kergueris MF, Pannier M, Jolliet P, Bourin M.
    Fundam Clin Pharmacol; 2003 Dec; 17(6):645-50. PubMed ID: 15015709
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
    Chan CY, Lai KN, Lam AW, Li PK, Chung WW, French GL.
    J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration.
    Mueller BA, Scarim SK, Macias WL.
    Am J Kidney Dis; 1993 Feb; 21(2):172-9. PubMed ID: 8430678
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.
    Tegeder I, Bremer F, Oelkers R, Schobel H, Schüttler J, Brune K, Geisslinger G.
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2640-5. PubMed ID: 9420033
    [Abstract] [Full Text] [Related]

  • 8. [Study on the pharmacokinetics of Imipenem cilastatin in burn patients during the acute phase].
    Wang H, Peng Y, Xiao G.
    Zhonghua Shao Shang Za Zhi; 2000 Dec; 16(6):349-51. PubMed ID: 11876899
    [Abstract] [Full Text] [Related]

  • 9. Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.
    Keller E, Fecht H, Böhler J, Schollmeyer P.
    Nephrol Dial Transplant; 1989 Dec; 4(7):640-5. PubMed ID: 2510062
    [Abstract] [Full Text] [Related]

  • 10. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
    Pietroski NA, Graziani AL, Lawson LA, Bland JA, Rogers JD, MacGregor RR.
    Antimicrob Agents Chemother; 1991 May; 35(5):972-5. PubMed ID: 1854179
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
    Fish DN, Teitelbaum I, Abraham E.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
    [Abstract] [Full Text] [Related]

  • 12. Using imipenem and cilastatin during continuous renal replacement therapy.
    Cotton A, Franklin BD, Brett S, Holmes A.
    Pharm World Sci; 2005 Oct; 27(5):371-5. PubMed ID: 16341743
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
    Kihara M, Ikeda Y, Shibata K, Masumori S, Ebira H, Shiratori K, Ueda S, Takagi N, Umemura S, Shionoiri H.
    Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of imipenem and cilastatin during continuous venovenous hemodialysis in patients who are critically ill.
    Hashimoto S, Honda M, Yamaguchi M, Sekimoto M, Tanaka Y.
    ASAIO J; 1997 Sep; 43(1):84-8. PubMed ID: 9116359
    [Abstract] [Full Text] [Related]

  • 15. Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance.
    Fratoni AJ, Mah JW, Nicolau DP, Kuti JL.
    J Antimicrob Chemother; 2022 Oct 28; 77(11):2992-2999. PubMed ID: 35906810
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of imipenem/cilastatin sodium in children with peritonitis.
    Claesson G, Eriksson M, Rogers JD.
    Pharmacol Toxicol; 1992 Aug 28; 71(2):103-6. PubMed ID: 1438026
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
    Verbist L, Verpooten GA, Giuliano RA, Debroe ME, Buntinx AP, Entwistle LA, Jones KH.
    J Antimicrob Chemother; 1986 Dec 28; 18 Suppl E():115-20. PubMed ID: 3469184
    [Abstract] [Full Text] [Related]

  • 18. Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment.
    Gomez DS, Sanches-Giraud C, Silva CV, Oliveira AM, da Silva JM, Gemperli R, Santos SR.
    J Antibiot (Tokyo); 2015 Mar 28; 68(3):143-7. PubMed ID: 25227503
    [Abstract] [Full Text] [Related]

  • 19. [Domestic imipenem cilastatin sodium for the treatment of severe aspiration pneumonia, a curative effect observation].
    Yin HY, Ye XL, Zhang R, Zhu YF.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Oct 28; 24(10):628-31. PubMed ID: 23040783
    [Abstract] [Full Text] [Related]

  • 20. [Clinical and pharmacokinetic evaluation of imipenem/cilastatin sodium in neonates and young infants].
    Sakata H, Kakehashi H, Fujita K, Murono K, Kaeriyama M, Oka T, Yoshioka H, Sasaki N, Mori Y, Maruyama S.
    Jpn J Antibiot; 1988 Nov 28; 41(11):1650-6. PubMed ID: 3210299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.